VISEN Pharmaceuticals (2561) Income Statement

Last quarter (Q2 2025), VISEN Pharmaceuticals's total revenue was ¥-880.50K, a decrease of -119.94% from the same quarter last year. In Q2, VISEN Pharmaceuticals's net income was ¥-59.01M. See VISEN Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.